ROCK has a crucial role in regulating prostate tumor growth through interaction with c-Myc

Oncogene

Volumn 33, Issue 49, 2014, Pages 5582-5591

  Zhang, C ^a,b   Zhang, S ^a   Zhang, Z ^b   He, J ^c   Xu, Y ^b   Liu, S ^a  

^a RESEARCH CENTER FOR ECO ENVIRONMENTAL SCIENCES   (China)

^b SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

^c Tufts University   (United States)

Author keywords

c Myc; proliferation; prostate cancer cells; protein stability; ROCK

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; AMIDE; HSPC111 PROTEIN, HUMAN; MESSENGER RNA; MICRORNA; MIRN17-92 MICRORNA, HUMAN; MYC PROTEIN; MYC PROTEIN, HUMAN; PROTEIN; PYRIDINE DERIVATIVE; RHO KINASE; ROCK1 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; CONFOCAL MICROSCOPY; CYTOSKELETON; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; MALE; METABOLISM; MOUSE; MUTAGENESIS; NUDE MOUSE; PHOSPHORYLATION; PHYSIOLOGY; PROSTATE TUMOR; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AMIDES; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYTOSKELETON; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MICROSCOPY, CONFOCAL; MUTAGENESIS; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; PYRIDINES; RHO-ASSOCIATED KINASES; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84888988014     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2013.505     Document Type: Article

References (43)

1. Narumiya S, Tanji M, Ishizaki T. Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev 2009; 28: 65-76.
2. Hahmann C, Schroeter T. Rho-kinase inhibitors as therapeutics: from pan inhibition to isoform selectivity. Cell Mol Life Sci 2010; 67: 171-177.
3. Bu QTH, Tan J, Hu X, Wang DW. Expression of RhoC and ROCK-1 and their effects on MAPK and Akt proteins in prostate carcinoma. Chin J Oncol 2011; 33: 202-206.
4. Liu S. The ROCK signaling and breast cancer metastasis. Mol Biol Rep 2011; 38: 1363-1366.
5. James K, Liao MS, Noma K. Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol 2007; 50: 17-24.
6. Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett 1996; 392: 189-193.
7. Riento K, Totty N, Villalonga P, Garg R, Guasch R, Ridley AJ. RhoE function is regulated by ROCK I-mediated phosphorylation. EMBO J 2005; 24: 1170-1180.
8. Zhang Y, Li X, Qi J, Wang J, Liu X, Zhang H et al. Rock2 controls TGFb signaling and inhibits mesoderm induction in zebrafish embryos. J Cell Sci 2009; 122: 2197-2207.
9. Lochhead PA, Wickman G, Mezna M, Olson MF. Activating ROCK1 somatic mutations in human cancer. Oncogene 2010; 29: 2591-2598.
10. Liu S, Goldstein RH, Scepansky EM, Rosenblatt M. Inhibition of Rho-associated kinase signaling prevents breast cancer metastasis to human bone. Cancer Res 2009; 69: 8742-8751.
11. Lane J, Martin TA, Watkins G, Mansel RE, Jiang WG. The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer. Int J Oncol 2008; 33: 585-593.
12. Lin S-L, Chang D, Ying S-Y. Hyaluronan stimulates transformation of androgenindependent prostate cancer. Carcinogenesis 2006; 28: 310-320.
13. Routhier A, Lahey D, Monfredo N, Johnson A, Callahan W, Partington A et al. Pharmacological inhibition of Rho-kinase signaling with Y-27632 blocks melanoma tumor growth. Oncogene Rep 2010; 23: 861-867.
14. Dang CV, O'Donnell KA, Zeller KI, Nguyen T, Osthus RC, Li F. The c-Myc target gene network. Sem Cancer Biol 2006; 16: 253-264.
15. Wang C, Lisanti MP, Liao DJ. Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology. Cell Cycle 2011; 10: 57-67.
16. Hann SR. Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function. Sem Cancer Biol 2006; 16: 288-302.
17. Watnick RS, Cheng Y-N, Rangarajan A, Ince TA, Weinberg RA. Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. Cancer Cell 2003; 3: 219-231.
18. Itoh K, Yoshioka K, Akedo H, Uehata M, Ishizaki T, Narumiya S. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 1999; 5: 221-225.
19. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997; 389: 990-994.
20. Chan CH, Lee SW, Li CF, Wang J, Yang WL, Wu CY et al. Deciphering the transcriptional complex critical for RhoA gene expression and cancer metastasis. Nat Cell Biol 2010; 12: 457-467.
21. Noguchi K, Kokubu A, Kitanaka C, Ichijo H, Kuchino Y. ASK1-signaling promotes c-Myc protein stability during apoptosis. Biochem Biophys Res Commun 2001; 281: 1313-1320.
22. Alarcon-Vargas D, Ronai Z. c-Jun-NH2 kinase (JNK) contributes to the regulation of c-Myc protein stability. J Biol Chem 2004; 279: 5008-5016.
23. Alarcon-Vargas D, Tansey WP, Ronai Z. Regulation of c-myc stability by selective stress conditions and by MEKK1 requires aa 127-189 of c-myc. Oncogene 2002; 21: 4384-4391.
24. Kenney AM, Widlund HR, Rowitch DH. Hedgehog and PI-3 kinase signaling converge on Nmyc1 to promote cell cycle progression in cerebellar neuronal precursors. Development 2004; 131: 217-228.
25. Seth A, Gupta S, Davis RJ. Cell cycle regulation of the c-Myc transcriptional activation domain. Mol Cell Biol 1993; 13: 4125-4136.
26. Luscher B, Eisenman RN. Mitosis-specific phosphorylation of the nuclear oncoproteins Myc and Myb. J Cell Biol 1992; 118: 775-784.
27. Butt A, Sergio CM, Inman C, Anderson L, McNeil C, Russell A et al. The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome. Breast Cancer Res 2008; 10: R28.
28. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M et al. Silencing of microRNAs in vivo with/'antagomirs/'. Nature 2005; 438: 685-689.
29. Hesan Luo JZ, Dong Z, Zeng Q, Wu D, Liu L. Up-regulated miR-17 promotes cell proliferation, tumour growth and cell cycle progression by targeting the RND3 tumour suppressor gene in colorectal carcinoma. Biochem J 2012; 442: 311-321.
30. Boku S, Nakagawa S, Toda H, Kato A, Takamura N, Omiya Y et al. ROCK2 regulates bFGF-induced proliferation of SH-SY5Y cells through GSK-3b and b-catenin pathway. Brain Res 2013; 1492: 7-17.
31. Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, Ivaldi G et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol 2004; 6: 308-318.
32. Gualco G WL, Harrington Jr WJ, Bacchi CE. Nodal diffuse large B-cell lymphomas in children and adolescents: immunohistochemical expression patterns and c-MYC translocation in relation to clinical outcome. Am J Surg Pathol 2009; 33: 1815-1822.
33. Ruzinova MB CT, Rodig SJ. Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation. Am J Surg Pathol 2010; 34: 882-891.
34. Alvarez E, Northwood IC, Gonzalez FA, Latour DA, Seth A, Abate C et al. Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation. Characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase. J Biol Chem 1991; 266: 15277-15285.
35. Seth A, Alvarez E, Gupta S, Davis RJ. A phosphorylation site located in the NH2-terminal domain of c-Myc increases transactivation of gene expression. J Biol Chem 1991; 266: 23521-23524.
36. Sears RC. The life cycle of C-myc: from synthesis to degradation. Cell Cycle 2004; 3: 1133-1137.
37. Welcker M, Orian A, Grim JA, Eisenman RN, Clurman BE. A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size. Curr Biol 2004; 14: 1852-1857.
38. Welcker M, Orian A, Jin J, Grim JA, Harper JW, Eisenman RN et al. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci USA 2004; 101: 9085-9090.
39. Popov N, Herold S, Llamazares M, Schulein C, Eilers M. Fbw7 and Usp28 regulate myc protein stability in response to DNA damage. Cell Cycle 2007; 6: 2327-2331.
40. Liu S, Li S, Du Y. Polychlorinated biphenyls (PCBs) enhance metastatic properties of breast cancer cells by activating Rho-associated kinase (ROCK). PLoS One 2010; 5: e11272.
41. Fontana L, Fiori ME, Albini S, Cifaldi L, Giovinazzi S, Forloni M et al. Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM. PLoS One 2008; 3: e2236.
42. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010; 18: 11-22.
43. Liu S, RNVS Suragani, Wang F, Han A, Zhao W, Andrews NC et al. The function of heme-regulated eIF2a kinase in murine iron homeostasis and macrophage maturation. J Clin Investig 2007; 117: 3296-3305.